Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities
Net income	$ 18,949	$ 3,149
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	12,026	15,440
Amortization of debt issuance costs	1,019	1,123
Stock-based compensation	6,135	5,502
Equity investment loss	0	4,407
Deferred income taxes	7,236	816
Loss on assets held for sale	1,527	0
Loss on disposals of long-lived assets	357	235
Loss on sale of subsidiary	2,764	0
Changes in operating assets and liabilities:
Accounts receivable, net of allowance for bad debt	16,430	8,325
Prepaid expenses	(990)	(4,651)
Income tax receivable	(6,683)	(4,886)
Operating leases, net	(364)	2,997
Other assets	(785)	(374)
Accounts payable	1,034	1,797
Accrued compensation and benefits	9,337	5,388
Accrued liabilities	2,734	4,516
Deferred revenue and student deposits	2,790	3,489
Net cash provided by operating activities	73,516	47,273
Investing activities
Cash outlay from the sale of subsidiary	(709)	0
Capital expenditures	(11,796)	(17,728)
Proceeds from the sale of real property	22,959	0
Net cash provided by (used in) investing activities	10,454	(17,728)
Financing activities
Cash paid for repurchase of common stock	(3,929)	(4,225)
Cash received from exercise of stock options	265	67
Preferred stock dividends paid	(2,751)	(4,597)
Cash paid for redemption of preferred stock	(43,192)	0
Cash paid for principal on borrowings and finance leases	(160)	(2,883)
Net cash used in financing activities	(49,767)	(11,638)
Net increase in cash, cash equivalents, and restricted cash	34,203	17,907
Cash, cash equivalents, and restricted cash at beginning of period	158,941	144,342
Cash, cash equivalents, and restricted cash at end of period	193,144	162,249
Supplemental disclosure of cash flow information
Interest paid	7,271	8,183
Income taxes paid	$ 6,393	$ 6,023